Veranova finishes mid-scale API expansion at Edinburgh facility
The multi-purpose asset, able to handle highly active APIs and intermediates, is positioned to enable growth in the generic opioid analgesic and anti-addiction markets
Macfarlan Smith | 28/02/2023 | By Sudeep Soparkar | 484
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy